AbCellera Biologics (ABCL) Operating Margin (QoQ) (2020 - 2026)
AbCellera Biologics (ABCL) Operating Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62,803.00 |
| Dec 31, 2025 | 78,807.00 |
| Sep 30, 2025 | -56,155.00 |
| Jun 30, 2025 | 118,933.00 |
| Mar 31, 2025 | -3,888.00 |
| Dec 31, 2024 | -127.00 |
| Sep 30, 2024 | -16,325.00 |
| Jun 30, 2024 | -72,469.00 |
| Mar 31, 2024 | 16,813.00 |
| Dec 31, 2023 | 11,218.00 |
| Sep 30, 2023 | -32,076.00 |
| Jun 30, 2023 | 2,107.00 |
| Mar 31, 2023 | -35,676.00 |
| Dec 31, 2022 | -21,256.00 |
| Sep 30, 2022 | 5,551.00 |
| Jun 30, 2022 | -8,934.00 |
| Mar 31, 2022 | 1,252.00 |
| Dec 31, 2021 | 56,863.00 |
| Sep 30, 2021 | -48,465.00 |
| Jun 30, 2021 | -10,341.00 |